Myriad Asset Management Advisors LLC Acquires Shares of 39,864 SPDR S&P Biotech ETF $XBI

Myriad Asset Management Advisors LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 39,864 shares of the exchange traded fund’s stock, valued at approximately $4,861,000. SPDR S&P Biotech ETF accounts for approximately 1.5% of Myriad Asset Management Advisors LLC’s investment portfolio, making the stock its 16th biggest position. Myriad Asset Management Advisors LLC owned 0.06% of SPDR S&P Biotech ETF as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Legacy Wealth Managment LLC ID bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $32,000. Greykasell Wealth Strategies Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $35,000. Ballast Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $36,000. Creative Financial Designs Inc. ADV bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $39,000. Finally, MCF Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $46,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $128.85 on Thursday. The company has a market capitalization of $8.22 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a fifty-two week low of $80.90 and a fifty-two week high of $139.19. The stock has a fifty day moving average of $132.43 and a 200-day moving average of $126.96.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Recommended Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.